查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464191

2024 年智慧吸入器全球市场报告

Smart Inhalers Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

智慧吸入器市场规模预计在未来几年将强劲成长。 2028年将成长至23.6亿美元，复合年增长率为9.8%。智慧吸入器在预测期内的预期增长是由于慢性呼吸道疾病（CRD）患病率上升、对家庭医疗保健解决方案的需求增加以及数位医疗保健技术的日益采用等因素造成的。预测期内预计的主要趋势包括智慧吸入器的技术进步、利用巨量资料分析进行呼吸健康管理、晶片感测器的结合以及感测器技术的进步，这些都将有助于发展更有效、对患者更友善的吸入器。

慢性呼吸道疾病（CRD）盛行率的增加将推动智慧吸入器市场的成长。慢性呼吸道疾病包括影响气道和肺部的长期疾病。智慧吸入器透过追踪使用情况并提供剂量提醒，在气喘和慢性阻塞性肺病等慢性呼吸道疾病的治疗中发挥重要作用。这确保了药物的持续使用，并有助于控制症状和防止病情恶化。根据澳洲健康与福利研究所 2023 年 6 月的报告，在澳大利亚，呼吸系统疾病相关死亡人数从 2020 年的 43,031 人增加到 2021 年的 46,551 人。此外，2022 年 9 月《采血针》资料显示，2021 年新患者呼吸道融合细胞病毒(RSV) 病例 11,255 例。 CRD 盛行率的上升是智慧吸入器市场的关键驱动因素。

智慧吸入器市场的主要企业正在积极开发数位呼吸健康解决方案等先进技术，以迎合更大的基本客群、增加销售并提高收益。数位呼吸健康解决方案是指旨在透过数位方式解决和管理呼吸健康状况的技术干预措施或平台。 2022 年 2 月，Aptar Pharma 推出了 HeroTracker Sense，这是一款充当数位呼吸健康解决方案的附加元件连接装置。该设备将标准定量喷雾吸入器(MDI) 转变为智慧型连线健诊医疗设备，专注于改善慢性呼吸道疾病患者的生活。 HeroTracker Sense 连接到 MDI 罐，具有追踪吸入调节、流量和持续时间的感测器。它透过伴同性应用程式提供讯息，提供带有日期和时间戳记的药物提醒，以及温度和湿度等环境监测警报。该设备旨在透过促进知情依从性来提高患者对处方治疗的依从性。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章 市场细分

  • 全球智慧吸入器市场：按类型分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 干粉吸入器 (DPI)
  • 定量喷雾吸入器(MDI)
  • 全球智慧吸入器市场：按适应症分類的表现与预测，2018-2023、2023-2028F、2033F
  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 其他适应症
  • 全球智慧吸入器市场：按分销管道分類的业绩和预测，2018-2023、2023-2028F、2033F
  • 医院药房
  • 零售药房
  • 网路药房
  • 全球智慧吸入器市场：最终用户的表现与预测，2018-2023、2023-2028F、2033F
  • 医院
  • 居家照护环境
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球智慧吸入器市场：按地区分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 全球智慧吸入器市场：按国家分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 智慧吸入器市场：竞争格局
  • 智慧吸入器市场：公司简介
    • Novartis AG
    • AstraZeneca Plc
    • GlaxoSmithKline Plc.
    • 3M Health Care Limited
    • Boehringer Ingelheim International GmbH

第31章 其他大型创新企业

  • Teva Pharmaceutical Industries Ltd.
  • Berry Global Group Inc.
  • Aptar Group Inc.
  • Lupin Limited
  • Findair Sp.Zoo
  • OPKO Health Inc.
  • Nemera France SAS
  • Vectura Group Limited
  • Propeller Health
  • Inspiro Medical Ltd.
  • Biocorp Production
  • Cohero Health Inc.
  • Pneuma Respiratory Inc.
  • Amiko Digital Health Limited
  • Cognita Labs LLC

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r16922

Smart inhalers are medical devices that incorporate connectivity with a mobile app, often through Bluetooth technology. These devices are designed to improve the user experience and offer more personalized treatment decisions for individuals dealing with chronic lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). Smart inhalers aim to enhance medication adherence, monitor inhaler usage, and provide valuable insights into the patient's respiratory health through the integration of digital technologies.

The primary types of smart inhalers include dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). Dry powdered inhalers (DPIs) are a specific type of inhaler designed to deliver medications, including inhaled corticosteroids, directly into the lungs. These inhalers are utilized in the treatment of various conditions such as asthma, chronic obstructive pulmonary disease (COPD), and others. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Smart inhalers, including DPIs, are employed by various end-users, including hospitals, homecare settings, and other healthcare facilities.

The smart inhalers market research report is one of a series of new reports from The Business Research Company that provides smart inhalers market statistics, including smart inhalers industry global market size, regional shares, competitors with a smart inhalers market share, detailed smart inhalers market segments, market trends, and opportunities, and any further data you may need to thrive in the smart inhalers industry. This smart inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart inhalers market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historical period can be attributed to factors such as increased medical adherence among patients, a growing emphasis on patient-centric healthcare, and an increasing demand for connected healthcare devices. These elements collectively contributed to the adoption and expansion of smart inhalers during the historic period, reflecting a trend towards more patient-engaged and technology-enabled healthcare solutions.

The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period for smart inhalers can be attributed to factors such as the rising prevalence of chronic respiratory diseases (CRDs), an increasing demand for home healthcare solutions, and the growing adoption of digital healthcare technologies. Major trends expected in the forecast period include technological advancements in smart inhalers, the utilization of big data analytics for respiratory health management, the incorporation of chip-on-sensors, and advancements in sensor technology, all of which contribute to the evolution of more effective and patient-friendly respiratory care solutions.

The increasing prevalence of chronic respiratory diseases (CRDs) is set to drive the growth of the smart inhaler market. Chronic respiratory diseases encompass a range of long-term conditions affecting the airways and lungs. Smart inhalers play a vital role in managing CRDs such as asthma and COPD by tracking usage and providing reminders for medication doses. This ensures consistent medication use, aiding in symptom control and preventing exacerbations. In Australia, respiratory disease-related deaths increased from 43,031 in 2020 to 46,551 in 2021, as reported by the Australian Institute of Health and Welfare in June 2023. Additionally, data from The Lancet in September 2022 revealed 11,255 new cases of respiratory syncytial virus (RSV) in 2021. The rising prevalence of CRDs is a significant driver for the smart inhaler market.

Major companies in the smart inhaler market are actively developing advanced technologies, such as digital respiratory health solutions, to cater to larger customer bases, increase sales, and boost revenue. Digital respiratory health solutions refer to technological interventions or platforms designed to address and manage respiratory health conditions through digital means. In February 2022, Aptar Pharma introduced the HeroTracker Sense, an add-on connected device serving as a digital respiratory health solution. This device transforms standard metered-dose inhalers (MDIs) into smart connected healthcare devices, focusing on improving the lives of patients with chronic respiratory diseases. HeroTracker Sense, attached to the MDI canister, features sensors to track inhalation coordination, flow rate, and duration. It provides information through a companion app, offering medication reminders with date and time stamps, along with environmental monitoring alerts such as temperature and humidity. The device aims to enhance patient adherence to prescribed therapies by facilitating informed and compliant medication intake.

In August 2022, AptarGroup Inc. acquired worldwide rights to the proprietary Orbital dry powder inhaler (DPI) from Pharmaxis Inc. for an undisclosed amount. Orbital technology is designed to deliver high-payload dry powder to the lungs without the need to reload, allowing patients to inhale powder payloads of up to 400mg in divided doses. This strategic acquisition strengthens Aptar Pharma's position in respiratory drug delivery devices and associated services. Pharmaxis Inc., an Australia-based pharmaceutical company, specializes in the development of dry powder inhalers (DPIs).

Major companies operating in the smart inhalers market report are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

North America was the largest region in the smart inhalers market in 2023. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart inhalers market consists of sales of pressurized MDIs (metered-dose inhalers), breath-actuated MDIs (metered-dose inhalers), and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Inhalers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart inhalers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Dry Powdered Inhalers (DPIs); Metered Dose Inhalers (MDIs)
  • 2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Other Indications
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 4) By End-User: Hospitals; Homecare Settings; Other End-Users
  • Companies Mentioned: Novartis AG; AstraZeneca Plc; GlaxoSmithKline Plc.; 3M Health Care Limited; Boehringer Ingelheim International GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Inhalers Market Characteristics

3. Smart Inhalers Market Trends And Strategies

4. Smart Inhalers Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Inhalers Market Size and Growth

  • 5.1. Global Smart Inhalers Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Inhalers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Inhalers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Inhalers Market Segmentation

  • 6.1. Global Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dry Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • 6.2. Global Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other Indications
  • 6.3. Global Smart Inhalers Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.4. Global Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare Settings
  • Other End-Users

7. Smart Inhalers Market Regional And Country Analysis

  • 7.1. Global Smart Inhalers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Inhalers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Inhalers Market

  • 8.1. Asia-Pacific Smart Inhalers Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Inhalers Market

  • 9.1. China Smart Inhalers Market Overview
  • 9.2. China Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Inhalers Market

  • 10.1. India Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Inhalers Market

  • 11.1. Japan Smart Inhalers Market Overview
  • 11.2. Japan Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Inhalers Market

  • 12.1. Australia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Inhalers Market

  • 13.1. Indonesia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Inhalers Market

  • 14.1. South Korea Smart Inhalers Market Overview
  • 14.2. South Korea Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Inhalers Market

  • 15.1. Western Europe Smart Inhalers Market Overview
  • 15.2. Western Europe Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Inhalers Market

  • 16.1. UK Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Inhalers Market

  • 17.1. Germany Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Inhalers Market

  • 18.1. France Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Inhalers Market

  • 19.1. Italy Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Inhalers Market

  • 20.1. Spain Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Inhalers Market

  • 21.1. Eastern Europe Smart Inhalers Market Overview
  • 21.2. Eastern Europe Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Inhalers Market

  • 22.1. Russia Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Inhalers Market

  • 23.1. North America Smart Inhalers Market Overview
  • 23.2. North America Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Inhalers Market

  • 24.1. USA Smart Inhalers Market Overview
  • 24.2. USA Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Inhalers Market

  • 25.1. Canada Smart Inhalers Market Overview
  • 25.2. Canada Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Inhalers Market

  • 26.1. South America Smart Inhalers Market Overview
  • 26.2. South America Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Inhalers Market

  • 27.1. Brazil Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Inhalers Market

  • 28.1. Middle East Smart Inhalers Market Overview
  • 28.2. Middle East Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Inhalers Market

  • 29.1. Africa Smart Inhalers Market Overview
  • 29.2. Africa Smart Inhalers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Inhalers Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Inhalers Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Inhalers Market Competitive Landscape And Company Profiles

  • 30.1. Smart Inhalers Market Competitive Landscape
  • 30.2. Smart Inhalers Market Company Profiles
    • 30.2.1. Novartis AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AstraZeneca Plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GlaxoSmithKline Plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. 3M Health Care Limited
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boehringer Ingelheim International GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Smart Inhalers Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Berry Global Group Inc.
  • 31.3. Aptar Group Inc.
  • 31.4. Lupin Limited
  • 31.5. Findair Sp.Z.o.o.
  • 31.6. OPKO Health Inc.
  • 31.7. Nemera France SAS
  • 31.8. Vectura Group Limited
  • 31.9. Propeller Health
  • 31.10. Inspiro Medical Ltd.
  • 31.11. Biocorp Production
  • 31.12. Cohero Health Inc.
  • 31.13. Pneuma Respiratory Inc.
  • 31.14. Amiko Digital Health Limited
  • 31.15. Cognita Labs LLC

32. Global Smart Inhalers Market Competitive Benchmarking

33. Global Smart Inhalers Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Inhalers Market

35. Smart Inhalers Market Future Outlook and Potential Analysis

  • 35.1 Smart Inhalers Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Smart Inhalers Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Smart Inhalers Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer